ASCO Direct 2026

Mysuru, 25-26 July 2026

A licensed ASCO event delivering the latest oncology research and clinical insights directly to India.

Highlights

Discover emerging therapies, clinical trials, and evidence-based updates that are transforming cancer care worldwide. Engage with leading oncologists, researchers, and healthcare professionals in an immersive experience that blends knowledge, clinical relevance, and practical applicability.

Access the latest ASCO Annual Meeting research

Gain practical, evidence-based insights for patient care

Learn directly from international and Indian oncology experts

Connect with a network of leading clinicians and researchers

ABOUT

About the Conference

ASCO Direct 2026 is a licensed educational event by the American Society of Clinical Oncology, designed to bring the latest oncology research and clinical innovations to Indian healthcare professionals.

The conference offers broad coverage of ASCO Annual Meeting studies, including:

Clinical trials and practice-changing results
Updates in medical oncology, hematology, and targeted therapies
Emerging treatments and innovations
Evidence-based strategies for patient care

Why Participate

ASCO Direct 2026 offers a high-value academic environment where participants can:

Engage with the latest oncology research and clinical developments
Gain insights from expert-led scientific sessions
Present research to a focused and relevant audience
Build connections with clinicians, researchers, and oncology leaders
Explore opportunities for collaboration, publication, and career advancement

Recognition & Opportunities

ASCO Direct 2026 is designed not only as a learning platform but also as a launchpad for academic and professional growth.

Participants will have the opportunity to present their work, engage with leading experts, and explore collaborations within the oncology community. The platform supports career progression, research visibility, and meaningful professional connections.

Selected participants may also gain opportunities for publication in the Journal of Precision Oncology, further extending the impact of their research.